ABSTRACT. The objective of this study was to evaluate the influence of c.1564A>T genetic polymorphisms in the multidrug resistance 1 gene (MDR1) on hepatocellular carcinoma (HCC) susceptibility through association analysis. A total of 632 HCC patients and 645 cancer-free controls were enrolled in this study. The c.1564A>T genetic polymorphisms were genotyped by created restriction sitepolymerase chain reaction (CRS-PCR) and confirmed using DNA sequencing methods. The potential associations of c.1564A>T genetic polymorphisms with the risk of HCC were analyzed by different genetic models. Statistically significantly increased risks of HCC were detected in the homozygote comparison (TT versus AA: OR = 1.70, 95%CI = 1.17-2.45, χ 2 = 7.99, P = 0.005), recessive model (TT versus AT/AA: OR = 1.64, 95%CI = 1.15-2.33, χ 2 = 7.66, P = 0.006), and allele contrast (T versus A: OR = 1.23, 95%CI = 1.04-1.45, χ 2 = 6.09, P = 0.014). Our data suggest that the genotypes/alleles from c.1564A>T genetic polymorphisms are 
INTRODUCTION
Hepatocellular carcinoma (HCC) is one of the most common malignant cancers and is the third leading cause of cancer-related deaths worldwide (Llovet et al., 2003; Parkin et al., 2005; Parikh and Hyman, 2007) . More than 600,000 people die from HCC each year, and about >75% of these HCC cases occur in the Asia-Pacific region Yuen et al., 2009 ). China has a very high HCC incidence, contributing to approximately 55% of all new annual cases of HCC in the world (Parkin et al., 2001 (Parkin et al., , 2005 Schutte et al., 2009) . HCC has been the second leading cause of cancer deaths in China since the 1990s (Chen et al., 2010) . Previous studies reported that the multidrug resistance 1 gene (MDR1) is an important candidate gene influencing HCC (Wu et al., 2007; Vander Borght et al., 2008; Chaijaroenkul et al., 2011; Chen et al., 2009 Chen et al., , 2011 Geng et al., 2011; Yu et al., 2011; Ren et al., 2012; Sun et al., 2012; Gao, 2013; Li et al., 2013; Yang et al., 2013) . MDR1 is a polygenetic gene and many genetic polymorphisms, such as G159T, T335C, C1236T, C1465T, G2677A/T, C3435T, A3073C, and A4125C, have been reported to have possible associations with the risk of HCC (Cavaco et al., 2003; Pechandova et al., 2006; Wu et al., 2007; Vander Borght et al., 2008; Chen et al., 2009 Chen et al., , 2011 Yu et al., 2011; Ren et al., 2012; Gao, 2013; Yang et al., 2013) . Several studies suggested that MDR1 genetic polymorphisms influenced HCC risk (Wu et al., 2007; Chen et al., 2009 Chen et al., , 2011 Ren et al., 2012; Gao, 2013; Yang et al., 2013) . However, the potential association between the c.1564A>T genetic polymorphism and HCC risk was not analyzed. Thus, this study aimed to evaluate whether this genetic polymorphism could influence HCC risk.
MATERIAL AND METHODS

Study population
In this case-control study, 1277 subjects were enrolled from The Huai'an First People's Hospital (Nanjing Medical University, Huai'an, Jiangsu, China) between January 2009 to December 2012, including 632 HCC patients and 645 cancer-free controls. All subjects were unrelated Han Chinese and lived in Huai'an city, Jiangsu Province of China. All HCC patients involved in this study were pathologically confirmed. Clinical characteristics are shown in Table 1 , including gender, age, tobacco smoking, alcohol drinking, hypertension, diabetes mellitus, hepatitis B virus (HBV) serological markers, serum alpha-fetoprotein (a-FP) levels, and family history of HCC. The control group was matched with the case group with regard to gender and age. Those with a history of HCC and other medical diseases were excluded. The local ethics committee approved this study and all subjects enrolled in this study gave written informed consent. 
Genotyping
Peripheral blood was collected from each subject. Genomic DNA was isolated from blood using the standard protocol (Daly et al., 1996) . The polymerase chain reaction (PCR) primers were designed through the Primer Premier 5.0 software (Premier Biosoft International; Palo Alto, CA, USA). The sequences of primers, amplification region, annealing temperature, and amplification fragment size, are shown in Table 2 . One of the primers contained a nucleotide mismatch, which enables the use of restriction enzymes for discriminating sequence variations (Haliassos et al., 1989; Zhao et al., 2003; Yuan et al., 2012 Yuan et al., , 2013a . The c.1564A>T genetic variants of MDR1 gene were genotyped by the created restriction site-PCR (CRS-PCR) method. To confirm the concordance of the CRS-PCR results, about 10% of the random samples were selected to verify the genetic variants by DNA sequencing method (ABI3730xl DNA Analyzer, Applied Biosystems, Foster City, CA, USA). PCR were carried out in a total volume of 20 µL solution, including 50 ng template DNA, 1X buffer (Tris-HCl 100 mM, pH 8.3; 500 mM KCl), 0.25 µM primers, 2.0 mM MgCl 2 , 0.25 mM dNTPs (Takara; Dalian, China), and 0.5 U Taq DNA polymerase (Promega; Madison, WI, USA). PCR cycle conditions were as follows: initial denaturation at 94°C for 5 min, followed by 32 cycles at 94°C for 30 s, 60.7°C for 30 s, at 72°C for 30 s, and a final extension at 72°C for 5 min. PCR amplified products were digested with 5 units selected MaeIII restriction enzyme (MBI Fermentas; St. Leon-Rot, Germany) at 37°C for 10 h, and then electrophoresed on 2.0% agarose gel containing ethidium-bromide and observed under UV light for analyzing the genotyping. MDR1 effect on hepatocellular carcinoma
Statistical analysis
The Hardy-Weinberg equilibrium of genotype frequencies, and the differences of clinical characteristics between HCC patients and cancer-free controls were evaluated using the chi-squared (χ 2 ) test. The odds ratios (ORs) with 95% confidence intervals (CIs) of the correlation with allele/genotype frequencies of HCC risk were evaluated by unconditional logistic regression models. All statistical analyses were analyzed by the Statistical Package for Social Sciences software (SPSS, Windows version release 14.0; SPSS Inc.; Chicago, IL, USA). A P value < 0.05 was considered to be statistically significant.
RESULTS
General characteristics
A total of 632 HCC patients and 645 cancer-free controls were recruited in this study. Table 1 shows the clinical characteristics of subjects. No statistically significant difference between HCC patients and cancer-free controls were found in regards to gender and age (P = 0.106 and P = 0.120, respectively). Furthermore, there were no statistically significant differences in other clinical characteristics, for example, tobacco smoking, alcohol drinking, diabetes mellitus, and hypertension, between HCC patients and cancer-free controls (P = 0.072, P = 0.107, P = 0.421, and P = 0.663, respectively).
Genotyping of MDR1 genetic polymorphism
We detected the c.1564A>T genetic polymorphism through the CRS-PCR method. The sequence analyses indicated that this genetic polymorphism was a non-synonymous mutation, which was caused by A to T mutations in exon15 of MDR1, leading to the threonine (Thr) to Serine (Ser) amino acid replacement (p.Thr522Ser). The amplified PCR products were digested with MaeIII restriction enzyme and divided into 3 genotypes: AA (198 and 22 bp), AT (220, 198, and 22 bp) , and TT (220 bp; Table 2 ). Table 3 shows the allele and genotype frequencies in HCC patients and cancer-free controls. The frequencies of allele-A and genotype-AA were predominant in the populations studied. The allele frequencies of HCC cases (A = 65.03%; T = 34.97%) were significantly different from those of cancer-free controls (A = 69.61%; T = 30.39%; χ 2 = 6.09, P = 0.014). The genotype frequencies in HCC cases (AA = 43.99%; AT = 42.09%; TT = 13.92%) were not consistent with cancer-free controls (AA = 48.22%; AT = 42.79%; TT = 8.99%), the differences being statistically significant (χ 2 = 8.07, P = 0.018). The distributions of genotype for this genetic polymorphism in the studied subjects did not significantly deviate from Hardy-Weinberg equilibrium (all P values > 0.05).
Groups
Genotype frequencies (%) Allele frequencies (%) Table 3 . Genotype and allele frequencies of c.1564A>T genetic polymorphisms in the MDR1 gene in cases and controls.
Association between MDR1 genetic polymorphism and HCC risk Table 4 shows the association between MDR1 genetic polymorphisms and the risk of HCC. We found a statistically significantly increased risk of HCC in the homozygote comparison (TT versus AA: OR = 1.70, 95% CI = 1.17-2.45, χ 2 = 7.99, P = 0.005), recessive model (TT versus AT/AA: OR = 1.64, 95% CI = 1.15-2.33, χ 2 = 7.66, P = 0.006) and allele contrast (T versus A: OR = 1.23, 95% CI = 1.04-1.45, χ 2 = 6.09, P = 0.014, Table 4 ). However, we failed to detect a statistically significantly increased risk of HCC in the heterozygote comparison (AT versus AA: OR = 1.08, 95% CI = 0.85-1.36, χ 2 = 0.40, P = 0.528) or the dominant model (TT/ AT versus AA: OR = 1.19, 95% CI = 0.95-1.48, χ 2 = 2.30, P = 0.130) ( 
DISCUSSION
HCC is a complex and multi-factorial process, in which both environmental and genetic factors interfere and contribute to malignant solid cancers (Marrero et al., 2005; Farazi and DePinho, 2006; El-Serag and Rudolph, 2007; Amarapurkar et al., 2008; Yu et al., 2012) . Emerging evidence suggests the genetic factors play key roles in HCC susceptibility (Thorgeirsson and Grisham, 2002; Nault and Zucman-Rossi, 2011; Bayram et al., 2012; Ning et al., 2012; Sumbul et al., 2012) . In recent years, several studies reported that the MDR1 gene is regarded as one of the most important candidate genes for HCC susceptibility, and the potential associations between MDR1 genetic polymorphisms and HCC risk have been analyzed (Wu et al., 2007; Chen et al., 2009 Chen et al., , 2011 Ren et al., 2012; Gao, 2013; Yang et al., 2013) . However, the findings from these observations remain conflicting rather than conclusive. In this study, we investigated the distribution of the c.1564A>T genetic polymorphism through the CRS-PCR method and evaluated the influence of this genetic polymorphism on HCC risk in the Chinese Han population by association analysis. Our data indicated statistically significant differences in allele and genotype frequencies between HCC cases and healthy controls ( Table  3 ). The TT genotype was significantly associated with increased risk of HCC compared to the AA genotype and AT/AA carriers ( Table 4 ). The allele T and genotype TT might contribute to HCC risk in the Chinese Han population. Our sequence analyses indicated that the c.1564A>T genetic polymorphism caused a p.Thr522Ser amino acid replacement. This amino acid replacement might affect the function of the MDR1 protein, which is significantly associated with susceptibility to HCC. The findings from the present study might add more evidence to evaluate the influence of the MDR1 gene on HCC risk.
In conclusion, this is the first report regarding the association of the c.1564A>T genetic polymorphism in the MDR1 gene with the risk of HCC. Our findings support the use of MDR1 genetic polymorphisms as molecular marker for evaluating susceptibility to HCC. Further studies will be needed to confirm these findings in large, different populations, and to help explain the molecular mechanisms.
